John C. Reed - EVP, Innovative Medicine, R&D at Johnson & Johnson

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Innovative Medicine, R&D
Stock Symbol
JNJ on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John C. Reed since 11/21/2023

Holdings reported by John C. Reed for Johnson & Johnson

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Share Units 53.5K $8.68M $162.16 May 1, 2024 Direct Common Stock
Restricted Share Units 50.5K $8.34M $165.06 May 1, 2024 Direct Common Stock
Employee Stock Options (Right to Buy) 65.2K $5.89M $90.44 Feb 15, 2024 Direct Common Stock
Common Stock 14.6K $2.11M $144.59 May 1, 2024 Direct

Transactions reported by John C. Reed for Johnson & Johnson

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.